Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: Histopathological features in tumour and non-tumour tissue

Journal of Clinical Pathology

Volumn 65, Issue 8, 2012, Pages 729-734

  Ryan, Paul ^a,b   Finelli, Antonio ^c   Lawrentschuk, Nathan ^c   Fleshner, Neil ^c   Sweet, Joan ^c   Cheung, Carol ^c   Van Der Kwast, Theodorus ^c   Evans, Andrew ^c  

^a BON SECOURS HOSPITAL   (Ireland)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROSIS; FOLLOW UP; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NECROSIS; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; STANDARD; STROMA; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; FIBROSIS; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; ONTARIO; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84864554010     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200460     Document Type: Article

References (22)

1. Klotz L. Active surveillance for prostate cancer: a review. Curr Urol Rep 2010;11:165-71.
2. Hamilton AS, Albertsen PC, Johnson TK, et al. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int 2011;107:576-84.
3. Lindner U, Trachtenberg J, Lawrentschuk N. Focal therapy in prostate cancer: modalities, findings and future considerations. Nat Rev Urol 2010;7:562-71.
4. Madersbacher S, Kratzik C, Susani M, et al. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol 1994;152:1956-60.
5. Chapelon JY, Ribault M, Vernier F, et al. Treatment of localised prostate cancer with transrectal high intensity focused ultrasound. Eur J Ultrasound 1999;9:31-8. (Pubitemid 29204699)
6. ter Haar GR. High intensity focused ultrasound for the treatment of tumors. Echocardiography 2001;18:317-22.
7. Warmuth M, Johansson T, Mad P. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer. Eur Urol 2010;58:803-15.
8. Lawrentschuk N, Finelli A, Van der Kwast TH, et al. Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer. J Urol 2011;185:862-8.
9. Kincaide LF, Sanghvi NT, Cummings O, et al. Noninvasive ultrasonic subtotal ablation of the prostate in dogs. Am J Vet Res 1996;57:1225-7.
10. Van Leenders GJ, Beerlage HP, Ruijter ET, et al. Histopathological changes associated with high-intensity focused ultrasound (HIFU) treatment for localized adenocarcinoma of the prostate. J Clin Pathol 2000;53:391-4. (Pubitemid 30256909)
11. Biermann K, Montironi R, Lopez-Beltran A, et al. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU). Prostate 2010;70:1196-200.
12. Evans AJ, Ryan P, van der Kwast T. Treatment effects in the prostate including those associated with traditional and emerging therapies. Adv Anat Pathol 2011;18:281-93.
13. Aus G. Current status of HIFU and cryotherapy in prostate cancer: a review. Eur Urol 2006;50:927-34. (Pubitemid 44486493)
14. Ahmed HU, Zacharakis E, Dudderidge T, et al. High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br J Cancer 2009;101:19-26.
15. Challacombe BJ, Murphy DG, Zakri R, et al. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up. BJU Int 2009;104:200-4.
16. Chalasani V, Martinez CH, Lim D, et al. Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis 2009;12:124-9.
17. Chalasani V, Martinez CH, Williams AK, et al. Histological changes in the human prostate after radiotherapy and salvage high intensity focused ultrasound. Can Urol Assoc J 2010;4:E100-2.
18. Blana A, Brown SC, Chaussy C, et al. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int 2009;104:1058-62.
19. Uchida T, Shoji S, Nakano M, et al. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Int J Urol 2009;16:881-6.
20. Ripert T, Azémar MD, Ménard J, et al. Six years' experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new 'Stuttgart' definition for biochemical failure. BJU Int 2011;107:1899-905.
21. Illing RO, Leslie TA, Kennedy JE, et al. Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: a proposed standard for the conduct of therapy. BJU Int 2006;98:1187-92. (Pubitemid 44721222)
22. Hou AH, Sullivan KF, Crawford ED. Targeted focal therapy for prostate cancer: a review. Curr Opin Urol 2009;19:283-9.